Global Oligonucleotide API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR102415042

Publication Date:

October 25, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Oligonucleotide API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The publisher report includes an overview of the development of the Oligonucleotide API industry chain, the market status of Contract Manufacturing Organizations (CMOs) (Antisense Oligonucleotides API, Small Interfering RNA (siRNA) API), Pharmaceutical Companies (Antisense Oligonucleotides API, Small Interfering RNA (siRNA) API), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oligonucleotide API.
Regionally, the report analyzes the Oligonucleotide API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oligonucleotide API market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oligonucleotide API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oligonucleotide API industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Ton), revenue generated, and market share of different by Type (e.g., Antisense Oligonucleotides API, Small Interfering RNA (siRNA) API).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oligonucleotide API market.
Regional Analysis: The report involves examining the Oligonucleotide API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oligonucleotide API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oligonucleotide API:
Company Analysis: Report covers individual Oligonucleotide API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oligonucleotide API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Contract Manufacturing Organizations (CMOs), Pharmaceutical Companies).
Technology Analysis: Report covers specific technologies relevant to Oligonucleotide API. It assesses the current state, advancements, and potential future developments in Oligonucleotide API areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oligonucleotide API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oligonucleotide API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Antisense Oligonucleotides API
Small Interfering RNA (siRNA) API
MiRNA API
CpG Oligonucleotides API
Others
Market segment by Application
Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
Major players covered
Jazz Pharmaceuticals
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics
Alnylam Pharmaceuticals
Nitto Denko (Avecia)
Ajinomoto (GeneDesign)
RiboBio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oligonucleotide API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oligonucleotide API, with price, sales, revenue and global market share of Oligonucleotide API from 2019 to 2024.
Chapter 3, the Oligonucleotide API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oligonucleotide API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oligonucleotide API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oligonucleotide API.
Chapter 14 and 15, to describe Oligonucleotide API sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of Oligonucleotide API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oligonucleotide API Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Antisense Oligonucleotides API
1.3.3 Small Interfering RNA (siRNA) API
1.3.4 MiRNA API
1.3.5 CpG Oligonucleotides API
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Oligonucleotide API Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Contract Manufacturing Organizations (CMOs)
1.4.3 Pharmaceutical Companies
1.5 Global Oligonucleotide API Market Size & Forecast
1.5.1 Global Oligonucleotide API Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oligonucleotide API Sales Quantity (2019-2030)
1.5.3 Global Oligonucleotide API Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Jazz Pharmaceuticals
2.1.1 Jazz Pharmaceuticals Details
2.1.2 Jazz Pharmaceuticals Major Business
2.1.3 Jazz Pharmaceuticals Oligonucleotide API Product and Services
2.1.4 Jazz Pharmaceuticals Oligonucleotide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Jazz Pharmaceuticals Recent Developments/Updates
2.2 Sarepta Therapeutics
2.2.1 Sarepta Therapeutics Details
2.2.2 Sarepta Therapeutics Major Business
2.2.3 Sarepta Therapeutics Oligonucleotide API Product and Services
2.2.4 Sarepta Therapeutics Oligonucleotide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sarepta Therapeutics Recent Developments/Updates
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Oligonucleotide API Product and Services
2.3.4 Biogen Oligonucleotide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biogen Recent Developments/Updates
2.4 Dynavax Technologies
2.4.1 Dynavax Technologies Details
2.4.2 Dynavax Technologies Major Business
2.4.3 Dynavax Technologies Oligonucleotide API Product and Services
2.4.4 Dynavax Technologies Oligonucleotide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Dynavax Technologies Recent Developments/Updates
2.5 Akcea Therapeutics
2.5.1 Akcea Therapeutics Details
2.5.2 Akcea Therapeutics Major Business
2.5.3 Akcea Therapeutics Oligonucleotide API Product and Services
2.5.4 Akcea Therapeutics Oligonucleotide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Akcea Therapeutics Recent Developments/Updates
2.6 Alnylam Pharmaceuticals
2.6.1 Alnylam Pharmaceuticals Details
2.6.2 Alnylam Pharmaceuticals Major Business
2.6.3 Alnylam Pharmaceuticals Oligonucleotide API Product and Services
2.6.4 Alnylam Pharmaceuticals Oligonucleotide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
2.7 Nitto Denko (Avecia)
2.7.1 Nitto Denko (Avecia) Details
2.7.2 Nitto Denko (Avecia) Major Business
2.7.3 Nitto Denko (Avecia) Oligonucleotide API Product and Services
2.7.4 Nitto Denko (Avecia) Oligonucleotide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Nitto Denko (Avecia) Recent Developments/Updates
2.8 Ajinomoto (GeneDesign)
2.8.1 Ajinomoto (GeneDesign) Details
2.8.2 Ajinomoto (GeneDesign) Major Business
2.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Product and Services
2.8.4 Ajinomoto (GeneDesign) Oligonucleotide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Ajinomoto (GeneDesign) Recent Developments/Updates
2.9 RiboBio
2.9.1 RiboBio Details
2.9.2 RiboBio Major Business
2.9.3 RiboBio Oligonucleotide API Product and Services
2.9.4 RiboBio Oligonucleotide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 RiboBio Recent Developments/Updates
3 Competitive Environment: Oligonucleotide API by Manufacturer
3.1 Global Oligonucleotide API Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oligonucleotide API Revenue by Manufacturer (2019-2024)
3.3 Global Oligonucleotide API Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Oligonucleotide API by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Oligonucleotide API Manufacturer Market Share in 2023
3.4.2 Top 6 Oligonucleotide API Manufacturer Market Share in 2023
3.5 Oligonucleotide API Market: Overall Company Footprint Analysis
3.5.1 Oligonucleotide API Market: Region Footprint
3.5.2 Oligonucleotide API Market: Company Product Type Footprint
3.5.3 Oligonucleotide API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oligonucleotide API Market Size by Region
4.1.1 Global Oligonucleotide API Sales Quantity by Region (2019-2030)
4.1.2 Global Oligonucleotide API Consumption Value by Region (2019-2030)
4.1.3 Global Oligonucleotide API Average Price by Region (2019-2030)
4.2 North America Oligonucleotide API Consumption Value (2019-2030)
4.3 Europe Oligonucleotide API Consumption Value (2019-2030)
4.4 Asia-Pacific Oligonucleotide API Consumption Value (2019-2030)
4.5 South America Oligonucleotide API Consumption Value (2019-2030)
4.6 Middle East and Africa Oligonucleotide API Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Oligonucleotide API Sales Quantity by Type (2019-2030)
5.2 Global Oligonucleotide API Consumption Value by Type (2019-2030)
5.3 Global Oligonucleotide API Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Oligonucleotide API Sales Quantity by Application (2019-2030)
6.2 Global Oligonucleotide API Consumption Value by Application (2019-2030)
6.3 Global Oligonucleotide API Average Price by Application (2019-2030)
7 North America
7.1 North America Oligonucleotide API Sales Quantity by Type (2019-2030)
7.2 North America Oligonucleotide API Sales Quantity by Application (2019-2030)
7.3 North America Oligonucleotide API Market Size by Country
7.3.1 North America Oligonucleotide API Sales Quantity by Country (2019-2030)
7.3.2 North America Oligonucleotide API Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Oligonucleotide API Sales Quantity by Type (2019-2030)
8.2 Europe Oligonucleotide API Sales Quantity by Application (2019-2030)
8.3 Europe Oligonucleotide API Market Size by Country
8.3.1 Europe Oligonucleotide API Sales Quantity by Country (2019-2030)
8.3.2 Europe Oligonucleotide API Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Oligonucleotide API Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oligonucleotide API Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oligonucleotide API Market Size by Region
9.3.1 Asia-Pacific Oligonucleotide API Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oligonucleotide API Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Oligonucleotide API Sales Quantity by Type (2019-2030)
10.2 South America Oligonucleotide API Sales Quantity by Application (2019-2030)
10.3 South America Oligonucleotide API Market Size by Country
10.3.1 South America Oligonucleotide API Sales Quantity by Country (2019-2030)
10.3.2 South America Oligonucleotide API Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Oligonucleotide API Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oligonucleotide API Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oligonucleotide API Market Size by Country
11.3.1 Middle East & Africa Oligonucleotide API Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oligonucleotide API Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Oligonucleotide API Market Drivers
12.2 Oligonucleotide API Market Restraints
12.3 Oligonucleotide API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Oligonucleotide API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oligonucleotide API
13.3 Oligonucleotide API Production Process
13.4 Oligonucleotide API Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oligonucleotide API Typical Distributors
14.3 Oligonucleotide API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Jazz Pharmaceuticals
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics
Alnylam Pharmaceuticals
Nitto Denko (Avecia)
Ajinomoto (GeneDesign)
RiboBio

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂